Healthcare advocates against Trump admin ending Medicare Part D subsidy program
Headline from WFLA, on the newest of 2 developments
"This decision shifts costs onto seniors and destabilizes traditional Medicare. I urge the administration to reverse this decision," Congresswoman Kathy Castor said in a statement
WFLA's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Subsidy program to end for Medicare
Headline from Arkansas Democrat-Gazette ·
Newest
Healthcare advocates against Trump admin ending Medicare Part D subsidy program
The Trump administration is planning to scrap Medicare subsidies, which could leave seniors facing higher rates for their prescription coverage next year. After 2026, the government will stop providing billions in subsidies to insurance companies that keep premiums low for Medicare prescription plan…
The Trump administration will end a subsidy program, meant to keep premiums stable for Medicare prescription drug plans, after 2026, the Centers for Medicare &Medicaid Services said on Tuesday.
The loss of the subsidy does not translate directly to how much premiums will rise, because companies that sell Medicare Part D drug coverage take into account many factors when setting rates.
The Centers for Medicare & Medicaid Services has announced the end of Part D subsidies for standalone prescription drug plans. CMS will discontinue the Part D Premium Stabilization Demonstration at the end of 2026.
The Trump administration on Tuesday said it would move to end a Biden-era Medicare premium subsidy program, alleging it benefitted insurance companies more than enrollees. As a result, Medicare Part D subsidies will expire at the end of the year and no longer be offered in 2027.
The Trump administration will end a subsidy program meant to keep premiums stable for Medicare prescription drug plans after 2026, the Centers for Medicare & Medicaid Services said on Tuesday.
Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of beneficiaries could face higher premiums in 2027.
(The Center Square) – A Biden-era health care subsidy under Medicare Part D will no longer be available in 2027, the Trump administration announced, as the costs of the prescription drug coverage plan continue to rise rapidly.
"This decision shifts costs onto seniors and destabilizes traditional Medicare. I urge the administration to reverse this decision," Congresswoman Kathy Castor said in a statement
To get prescription drugs in America, you often have to spend an egregious amount for each refill, especially if you don’t have health insurance. Medicare Part D, also known as Medicare drug coverage , aimed to help solve that issue.
Millions of older adults on Medicare prescription drug coverage could face higher monthly costs in 2027. The Trump administration said this week it has decided to end a temporary subsidy program that helped offset premiums for the past two years.…
Millions of older adults on Medicare prescription drug coverage could face higher monthly costs in 2027. The Trump administration said this week it has decided to end a temporary subsidy program that helped offset premiums for the past two years.
Federal officials insist the financial impact on Medicare beneficiaries will be minimal. The decision opens the Republican-led administration to potential political consequences.
ROCHESTER, N.Y. — A federal subsidy intended to help stabilize Medicare Part D premiums is ending at the end of 2026. The change could impact seniors who have regular Medicare and then an added Part D plan for prescriptions coverage, those with Medicare Advantage plan are not impacted.
The Trump administration announced this week it is making a key change to Medicare, a federal health insurance program widely used in the United States. Medicare is a government-funded program managed by the Centers for Medicare & Medicaid Services.
CMS Administrator Dr. Mehmet Oz said on Tuesday that ending the $3.6 billion program would prevent billions of taxpayer dollars from going to insurance companies.
